Immunochemical detection of imidazolone in uremia and rheumatoid arthritis

Clinica Chimica Acta

Volumn 300, Issue 1-2, 2000, Pages 29-41

  Franke, S ^a   Niwa, T ^b   Deuther Conrad, W ^a   Sommer, M ^a   Hein, G ^a   Stein, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

2 microglobulin; 3 Deoxyglucosone; Advanced glycation end product; Chronic renal failure; Imidazolone; Rheumatoid arthritis

Indexed keywords

3 DEOXYGLUCOSONE; ADVANCED GLYCATION END PRODUCT; ALBUMIN; ARGININE; BETA 2 MICROGLOBULIN; GLUCOSE; IMIDAZOLE DERIVATIVE; IMIDAZOLONE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; MALE; OXIDATION; PRIORITY JOURNAL; REACTION ANALYSIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; UREMIA; URINALYSIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMIDAZOLES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; UREMIA;

EID: 0033839467     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00299-0     Document Type: Article

References (30)

1. Vlassara H., Bucala R., Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest. 70:1994;138-151.
2. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med. 46:1995;223-234.
3. Vlassara H. Pathogenesis of diabetic nephropathy, advanced glycation and new therapy. Med Klin. 92:(Suppl 1):1997;29-34.
4. Vlassara H. Protein glycation in the kidney. Role in diabetes and aging. Kidney Int. 49:1996;1795-1804.
5. Vlassara H. Advanced glycation end-products and atherosclerosis. Ann Med. 28:1996;419-426.
6. Colaco C.A.L.S., Ledesma M.D., Harrington C.R., Avila J. The role of the Maillard reaction in other pathologies: Alzheimer's disease. Nephrol Dial Transplant. 11:(Suppl 5):1996;7-12.
7. Miyata T., Lida Y., Horie K., Cai Z., Sugiyama S., Maeda K. Pathophysiology of advanced glycation end-products in renal failure. Nephrol Dial Transplant. 11:(Suppl 5):1996;27-80.
8. Friedlander M.A., Wu Y.C., Elgawish A., Monnier V.M. Early and advanced glycosylation end products - kinetics of formation and clearance in peritoneal dialysis. J Clin Invest. 97:1996;728-735.
9. 2-m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum. Kidney Int. 49:1996;861-867.
10. Wells-Knecht K.J., Zyzak D.V., Litchfield J.E., et al. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry. 34:1995;3702-3709.
11. Requena R.J., Fu M.X., Ahmed M.U., et al. Lipid peroxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol Dial Transplant. 11:(Suppl 5):1996;48-53.
12. ε-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest. 99:1997;457-468.
13. Sell D.R., Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem. 264:1989;21597-21602.
14. Wells-Knecht K.J., Brinkmann E., Wells-Knecht M.C., et al. New biomarkers of Maillard reaction damage to proteins. Nephrol Dial Transplant. 11:(Suppl 5):1996;41-47.
15. ε-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int. 50:1996;1303-1309.
16. Konishi Y., Hayase F., Kato H. Novel imidazolone compound formed by the advanced Maillard reaction of 3-deoxyglucosone and arginine residues in proteins. Biosci Biotechnol Biochem. 58:1994;1953-1955.
17. Hayase F., Nagaraj R.H., Miyata S., Njoroge F.G., Monnier V.M. Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J Biol Chem. 264:1989;3758-3764.
18. Dyer D.G., Blackledge J.A., Thorpe S.R., Baynes J.W. Formation of pentosidine during nonenzymatic browning of proteins by glucose. J Biol Chem. 266:1991;11654-11660.
19. 2-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products. Nephron. 76:1997;373-391.
20. 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis. Kidney Int. 51:1997;187-194.
21. Niwa T., Katsuzaki T., Miyazaki S., et al. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidney and aortas of diabetic patients. J Clin Invest. 99:1999;1272-1280.
22. Miyata T., Ishiguro N., Yasuda Y., et al. Increased pentosidin, an advanced glycation end product, in synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem Biophys Res Commun. 244:1998;45-49.
23. Niwa T., Miyasaki S., Katsuzaki T., et al. Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. Kidney Int. 48:1995;771-778.
24. Eckert W.A., Kartenberg J. Proteine: Standardmethoden der Molekular- und Zellbiologie. 1997;Springer, Berlin.
25. Anderson L., Anderson N.G. High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci USA. 74:1977;5421-5425.
26. Westwood M.E., Thornalley P.J. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J Prot Chem. 14:1995;359-372.
27. Lo T.W., Westwood M.E., McLellan A.C., et al. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-cysteine, and N alpha-acetyllysine, and bovine serum albumine. J Biol Chem. 269:1994;32299-32305.
28. Odani H., Shinzato T., Usami J., et al. Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia. FEBS Lett. 427:1998;381-385.
29. Argilès A., Garcia-Garcia M., Derancourt J., et al. Beta 2 microglobulin isoforms in healthy individuals and in amyloid deposits. Kidney Int. 48:1995;1397-1405.
30. 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis. Nephrol Dial Transplant. 11:(Suppl 3):1996;86-90.